EATG » Tuberculosis

Tuberculosis

At AIDS 2018, advocates want action from world leaders to end TB-HIV

Amsterdam, The Netherlands (July 23, 2018) — In preparation for the first ever United Nation’s High-Level Meeting (UNHLM) on tuberculosis (TB), to be held September 26, in New York, advocates…

2018 TAG Pipeline Report

Treatment Action Group (TAG) released the 2018 Pipeline Report - TAG’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, HCV, and TB, along with immune-based…

Global Fund and ICRC join forces to enhance response to HIV, TB and malaria in conflict-affected areas

Geneva, 16 July 2018 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and the International Committee of the Red Cross (ICRC) met Monday to announce…

How many people die from TB every year?

A study explores why the global estimates for tuberculosis mortality differ according to the institution that provides them The discrepancies between the estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for…

Advocates call for policies to support all-oral regimens for children with drug-resistant TB

Advocates release recommendations for injectable-free regimens for children under the age of 12 years. The Desmond Tutu Tuberculosis Centre (DTTC), the Sentinel Project on Pediatric Drug-Resistant Tuberculosis and Treatment Action…

Activists call on Johnson & Johnson to drop the price of bedaquiline

Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower. South Africa’s Department of Health recently announced that it will replace…

NEJM publishes final results from Phase 2 study showing vaccines can reduce rate of sustained TB infections

Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against TB, the world’s leading infectious disease killer. ROCKVILLE, MARYLAND (JULY 11, 2018) -- Aeras, a nonprofit organization dedicated…

South African TB study finds lower death rate with bedaquiline

In a study that could have an impact on the treatment of drug-resistant tuberculosis (TB), a team of South African researchers report that the novel TB drug bedaquiline was associated…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 338 of the ‘Global Fund Observer.’ The newsletter includes articles…

Communities and Civil Society Communiqué on the draft multi-sectoral framework to accelerate progress to end TB

Representatives of communities affected by TB and civil society organizations met in Bangkok on 24 June 2018 to formulate a civil society position on TB accountability, guided by the draft…